Jasper Therapeutics Stock Price To Earnings To Growth
| JSPRW Stock | USD 0.13 0.00 0.00% |
Fundamental analysis of Jasper Therapeutics allows traders to better anticipate movements in Jasper Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Jasper | Price To Earnings To Growth | Build AI portfolio with Jasper Stock |
Jasper Therapeutics Company Price To Earnings To Growth Analysis
Jasper Therapeutics' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Jasper Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Jasper Therapeutics is extremely important. It helps to project a fair market value of Jasper Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Jasper Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Jasper Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Jasper Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Jasper Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Jasper Therapeutics has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Jasper Fundamentals
| Return On Equity | -1.91 | ||||
| Return On Asset | -0.73 | ||||
| Number Of Shares Shorted | 16.61 K | ||||
| EBITDA | (74.87 M) | ||||
| Net Income | (71.27 M) | ||||
| Cash And Equivalents | 16.76 M | ||||
| Cash Per Share | 1.65 X | ||||
| Total Debt | 1.81 M | ||||
| Debt To Equity | 0.22 % | ||||
| Current Ratio | 1.96 X | ||||
| Book Value Per Share | 0.41 X | ||||
| Cash Flow From Operations | (62.6 M) | ||||
| Earnings Per Share | (3.84) X | ||||
| Number Of Employees | 27 | ||||
| Beta | 3.06 | ||||
| Total Asset | 79.9 M | ||||
| Retained Earnings | (240.87 M) | ||||
| Working Capital | 60.57 M | ||||
| Net Asset | 79.9 M |
About Jasper Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jasper Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jasper Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jasper Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price |
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.